Indeed, previous work has shown that B16‐F1‐derived Ag can be directly presented by tumor cells to CD8+ T cells within the lung‐draining paratracheal LN at 14 days post‐intravenous tumor challenge [14]. The gene discussed is CD8A; the disease is neoplasm.